Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关实验视频

里芬素和多发性硬化症

H S Rosenkranz

    Lancet (London, England)
    |December 23, 1972
    PubMed
    概括

    No abstract available in PubMed .

    相关实验视频

    相关概念视频

    您也可能阅读

    相关文章

    通过共同作者、期刊和引用图与本文相关的文章。

    排序
    Same author

    The Development and Characterisation of a Structure-activity Relationship Model of the Draize Eye Irritation Test.

    Alternatives to laboratory animals : ATLA·2015
    Same author

    The High Production Volume Chemical Challenge Program : The Rodent LD50 and its Possible Replacement.

    Alternatives to laboratory animals : ATLA·2014
    Same author

    Structural Basis of the Toxicity of Chemicals in Cultured Human HeLa Cells.

    Alternatives to laboratory animals : ATLA·2014
    Same author

    A battery of cell toxicity assays as predictors of eye irritation: a feasibility study.

    Alternatives to laboratory animals : ATLA·2014
    Same author

    Structure-activity approach to the identification of environmental estrogens: the MCASE approach.

    SAR and QSAR in environmental research·2004
    Same author

    A substructure-based SAR model for odor perception in humans relevant to health risk assessments.

    SAR and QSAR in environmental research·2003
    Same journal

    Assisted dying and the silencing of medicine's next generation.

    Lancet (London, England)·2026
    Same journal

    Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

    Lancet (London, England)·2026
    Same journal

    Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

    Lancet (London, England)·2026
    Same journal

    [<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

    Lancet (London, England)·2026
    Same journal

    Research priorities for characterising Bundibugyo virus.

    Lancet (London, England)·2026
    Same journal

    Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

    Lancet (London, England)·2026
    查看所有相关文章